SCHEMBL13768826

SCHEMBL13768826

C=C1CC2C(CC[C@](CC)(CCCC(=O)O)C2[C@H]2C[C@H]2C)C2CCC(=N)C=C12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13796902 0.81 PGR (0.34) —
SCHEMBL13768466 0.78 CYP19A1 (0.37) —
SCHEMBL13556656 0.75 SHBG (0.44) —
SCHEMBL13769269 0.73 PDK1 (0.31) —
SCHEMBL13796510 0.73 PGR (0.47) —
SCHEMBL13768718 0.71 AR (0.45) —
SCHEMBL13768840 0.70 PGR (0.36) —
SCHEMBL13796904 0.70 PGR (0.37) —
SCHEMBL13796898 0.66 AR (0.32) —
SCHEMBL13796033 0.66 CYP19A1 (0.35) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009083272-A2 19-NOR-STEROID DERIVATIVES WITH A 15α,16α-METHYLENE GROUP AND A SATURATED 17,17-SPIROLACTONE RING, USE THEREOF, AND MEDICAMENTS CONTAINING SAID DERIVATIVES BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2009-07-09 — — WO disclosed
Send feedback